MEDSECUREAN.COM

Lobbying for LUPIN PHARMACEUTICALS · Lupin Pharmaceuticals is a generic manufacturing company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Florida · Senate · $54,000.00 income · posted Jul 13, 2026

Lobbying activity 2

Health Issues

Policies that promote the long-term sustainability of the U.S. generic pharmaceutical industry and preserve reliable patient access to affordable medicines.

Trade (domestic/foreign)

Tarrifs - generic medicine

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.